Work

Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease

Year: 2020

Type: article

Study design: Observational Study

Source: Inflammatory Bowel Diseases

DOI: 10.1093/ibd/izaa313

Authors: Robert Battat, Dana Lukin, Ellen J Scherl, Suresh Pola, Anand Kumar, Lauren Okada, Lei Yang, Anjali Jain, Corey A Siegel

Institutions: Weill Cornell Medicine, Kaiser Permanente, Kaiser Permanente San Diego Medical Center, Prometheus Biosciences (United States), Dartmouth–Hitchcock Medical Center

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3110054006

FWCI: 2.195

Cites: 42

Cited by: 26

Related to: 10